Buy These 3 Dividend Stocks Today and Thank Yourself in 20 Years

Coca-Cola posted 2025 case volume growth of 1% and organic sales growth of 5%, with Q1 2026 case volume up 3% and organic sales up 10%, supporting a 2.6% dividend yield and modestly attractive valuation. General Mills reported organic sales down 3%, gross margin down 200 bps, and adjusted earnings down 25% through the first nine months of fiscal 2026, though it reaffirmed full-year guidance. Hormel’s organic growth has risen for more than a year, suggesting its turnaround is gaining traction despite continued earnings pressure.

Analysis

The setup is less about absolute fundamentals and more about dispersion within a defensive basket. KO is the cleanest quality compounder: if growth stays mid-single digits while capital returns remain intact, it can keep absorbing macro fear without multiple compression, especially as income buyers rotate toward names with visible pricing power and lower earnings volatility. The second-order effect is that branded staples with stronger shelf power should continue to take share from weaker private-label-sensitive peers as retailers rationalize inventory and consumers trade down selectively rather than uniformly.

GIS looks like a balance-sheet-and-sentiment trade, not a clean operating recovery. The market is pricing in the risk that investment spending today becomes permanent margin leakage, but the more interesting catalyst is simply stabilization: if gross margin stops deteriorating and management can show the portfolio reset is landing, the stock can re-rate faster than earnings recover because expectations are already depressed. The high yield is doing a lot of the work here, and that creates a reflexive floor unless there is a real cut-risk signal.

HRL is the most underappreciated because its turnaround has a clearer link to current consumer behavior. Protein-heavy positioning is a rare way for a packaged-food company to align with GLP-1 adoption rather than be punished by it, and that could eventually show up in category mix, not just top-line growth. The key risk is that margin improvement lags volume improvement, so the stock can stay cheap longer than the operating data deserves if investors remain focused on near-term earnings pressure.

Contrarianly, the market may be over-discounting the entire group on a cyclical read when parts of the weakness are self-correcting portfolio shifts. The bigger risk is not demand collapse but duration: these names need 2-4 quarters of cleaner margin math and still may not get credit until it is visible in reported earnings. That makes relative-value positioning more attractive than outright longs until the next few prints confirm the turn.

Key Decisions for Investors

• Long KO as a defensive quality anchor for 6-12 months; target low-volatility total return with limited downside unless organic growth materially decelerates.
• Buy a small starter long in HRL for a 12-18 month turnaround trade; risk/reward improves if earnings remain pressured but organic growth continues to inflect, because the market should re-rate on evidence of execution before EPS fully recovers.
• Avoid outright GIS size until the margin trough is visible; if forced to express the view, use a small long only after the next earnings release confirms stabilization, otherwise the stock can dead-money on investment spending for another 1-2 quarters.
• Pair trade: long HRL / short GIS over the next 3-6 months to express relative turnaround quality versus a slower portfolio reset; thesis works if protein mix and organic growth continue to outperform while GIS remains a margin story.
• For income-focused exposure, favor KO over GIS and HRL for lower tail risk; for higher yield, use HRL over GIS because the operating inflection gives better upside optionality if sentiment turns.